The results showed higher expression of the STAT1 signaling pathway downstream response genes in the low-grade (WHO I/II) glioma group compared with the high-grade (WHO III/IV) glioma group (Figure 5, E and F, and Supplemental Figure 9B). Here, STAT1 is linked to central nervous system cancer.